Park Medi World IPO

Park Medi World IPO
Park Medi World Limited, established in 2011, is the second largest private hospital chain in North India and the largest in Haryana, operating 14 NABH and NABL accredited multi-super speciality hospitals under the 'Park' brand. With a total bed capacity of 3,250 as of September 30, 2025, the company offers over 30 specialities, including oncology, orthopaedics, and critical care. The business employs a cluster-based expansion strategy and has a strong track record of successfully acquiring and integrating hospitals, contributing significantly to its revenue and profitability.
Investment Timeline
🤖 Smart Analysis
*AI score is algorithmic and for educational purposes only.
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
👍 Flexible timing - Apply by Day 3, good allotment chances
Key Factor Analysis
Issue Details
Object of the Issue
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries (₹380.00 Cr).
- Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively (₹60.50 Cr).
- Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri (₹27.46 Cr).
- Unidentified inorganic acquisitions and general corporate purposes.
Frequently Asked Questions
What is the current GMP of Park Medi World IPO?
What is the AI Prediction for Park Medi World IPO?
When will the allotment for Park Medi World IPO be announced?
What is the listing date for Park Medi World IPO?
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.